Sunshine Biopharma, Inc.
SBFM
$1.25
$0.032.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.69M | 12.21M | 11.51M | 17.43M | 16.29M |
| Total Receivables | 3.87M | 3.22M | 3.97M | 2.83M | 2.55M |
| Inventory | 11.28M | 9.82M | 8.49M | 7.70M | 5.73M |
| Prepaid Expenses | 1.13M | 735.80K | 1.78M | 871.40K | 310.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.97M | 25.98M | 25.75M | 28.83M | 24.89M |
|
|
|||||
| Total Current Assets | 25.97M | 25.98M | 25.75M | 28.83M | 24.89M |
| Net Property, Plant & Equipment | 1.48M | 1.13M | 1.11M | 1.00M | 1.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.02M | 2.94M | 2.45M | 2.07M | 1.44M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 92.20K | -- | -- | -- | -- |
| Total Assets | 30.56M | 30.06M | 29.30M | 31.90M | 27.35M |
|
|
|||||
| Total Accounts Payable | 5.54M | 4.16M | 4.93M | 3.62M | 2.59M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 207.80K | 116.30K | 114.50K | 115.40K | 118.70K |
| Total Finance Division Other Current Liabilities | 564.10K | 255.00K | 255.00K | 2.80M | 2.85M |
| Total Other Current Liabilities | 564.10K | 255.00K | 255.00K | 2.80M | 2.85M |
| Total Current Liabilities | 6.31M | 4.53M | 5.30M | 6.53M | 5.55M |
|
|
|||||
| Total Current Liabilities | 6.31M | 4.53M | 5.30M | 6.53M | 5.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 744.70K | 440.30K | 462.90K | 497.00K | 539.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 48.70K | 48.70K | 48.70K | 48.70K |
| Total Liabilities | 7.06M | 5.02M | 5.81M | 7.08M | 6.14M |
|
|
|||||
| Common Stock & APIC | 93.36M | 91.74M | 89.84M | 89.84M | 84.42M |
| Retained Earnings | -69.04M | -66.88M | -65.68M | -65.19M | -63.91M |
| Treasury Stock & Other | -830.00K | 168.60K | -683.10K | 152.40K | 696.10K |
| Total Common Equity | 23.49M | 25.03M | 23.48M | 24.81M | 21.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 13.00K | 13.00K | 13.00K | 13.00K | 1.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 1.00K |
|
|
|||||
| Total Common Equity | 23.49M | 25.03M | 23.48M | 24.81M | 21.21M |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.50M | 25.04M | 23.49M | 24.82M | 21.21M |
|
|
|||||